ClinicalTrials.Veeva

Menu
V

Vivent Health | Denver, CO

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Islatravir
Lenacapavir
Bictegravir
Tenofovir Alafenamide
Descovy
Ulonivirine
MK-8591B-062
Emtricitabine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 7 total trials
Locations recently updated

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Researchers are looking for new ways to treat HIV-1 (Human Immunodeficiency Virus Type 1). The usual (standard) treatment for HIV-1 is antiretroviral...

Enrolling
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Drug: ISL/ULO
Drug: ULO

This is a randomized, active-controlled, double-blind clinical study designed to evaluate the antiretroviral activity, safety, and tolerability of do...

Active, not recruiting
HIV-1 Infection
Drug: BIC/FTC/TAF
Drug: Placebo to DOR/ISL
Locations recently updated

The primary objective of this study is to evaluate the efficacy of oral weekly islatravir (ISL) in combination with lenacapavir (LEN) in virologicall...

Active, not recruiting
HIV-1 Infection
Drug: ISL/LEN FDC
Drug: B/F/TAF

The goal of this clinical study is to learn about the safety and efficacy of switching to once weekly tablet of islatravir/lenacapavir (ISL/LEN) regi...

Active, not recruiting
HIV-1-infection
Drug: B/F/TAF
Drug: PTM ISL/LEN

The goal of this clinical study is to learn more about the safety and efficacy of switching to a once weekly tablet of islatravir/lenacapavir (ISL/LE...

Active, not recruiting
HIV-1-Infection
Drug: Antiretroviral Combinations
Drug: ISL/LEN

Trial sponsors

Gilead Sciences logo
Merck Sharp & Dohme (MSD) logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems